Orthostatic	orthostatic	O	DISEASE	OTHERS	I
hypotension	hypotension	O	DISEASE	OTHERS	I
occurs	occurs	O	O	O	O
following	following	O	O	O	O
alpha	alpha	O	O	O	O
2-adrenoceptor	2-adrenoceptor	O	O	O	O
blockade	blockade	O	O	O	O
in	in	O	O	O	O
chronic	chronic	O	O	O	O
prazosin-pretreated	prazosin-pretreated	O	O	O	O
conscious	conscious	O	O	O	O
spontaneously	spontaneously	O	O	O	O
hypertensive	hypertensive	O	DISEASE	OTHERS	I
rats.1	rats.1	O	O	O	O
.	.	O	O	O	O

Studies	studies	O	O	O	O
were	were	O	O	O	O
performed	performed	O	O	O	O
to	to	O	O	O	O
evaluate	evaluate	O	O	O	O
whether	whether	O	O	O	O
chronic	chronic	O	O	O	O
prazosin	prazosin	CHEMICALS	O	OTHERS	I
treatment	treatment	O	O	O	O
alters	alters	O	O	O	O
the	the	O	O	O	O
alpha	alpha	O	O	O	O
2-adrenoceptor	2-adrenoceptor	O	O	O	O
function	function	O	O	O	O
for	for	O	O	O	O
orthostatic	orthostatic	O	O	O	O
control	control	O	O	O	O
of	of	O	O	O	O
arterial	arterial	O	O	O	O
blood	blood	O	O	O	O
pressure	pressure	O	O	O	O
in	in	O	O	O	O
conscious	conscious	O	O	O	O
spontaneously	spontaneously	O	O	O	O
hypertensive	hypertensive	O	DISEASE	OTHERS	I
rats	rats	O	O	O	O
(	(	O	O	O	O
SHR	shr	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

2	2	O	O	O	O
.	.	O	O	O	O
Conscious	conscious	O	O	O	O
SHR	shr	O	O	O	O
(	(	O	O	O	O
male	male	O	O	O	O
300	300	O	O	O	O
-	-	O	O	O	O
350	350	O	O	O	O
g	g	O	O	O	O
)	)	O	O	O	O
were	were	O	O	O	O
subjected	subjected	O	O	O	O
to	to	O	O	O	O
90	90	O	O	O	O
degrees	degrees	O	O	O	O
head-up	head-up	O	O	O	O
tilts	tilts	O	O	O	O
for	for	O	O	O	O
60	60	O	O	O	O
s	s	O	O	O	O
following	following	O	O	O	O
acute	acute	O	O	O	O
administration	administration	O	O	O	O
of	of	O	O	O	O
prazosin	prazosin	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
0.1	0.1	O	O	O	O
mg	mg	O	O	OTHERS	I
kg-1	kg-1	O	O	O	O
i.p	i.p	O	O	O	O
.	.	O	O	O	O
)	)	O	O	O	O
or	or	O	O	O	O
rauwolscine	rauwolscine	O	O	OTHERS	I
(	(	O	O	O	O
3	3	O	O	O	O
mg	mg	O	O	OTHERS	I
kg-1	kg-1	O	O	O	O
i.v	i.v	O	O	O	O
.	.	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Orthostatic	orthostatic	O	DISEASE	OTHERS	I
hypotension	hypotension	O	DISEASE	OTHERS	I
was	was	O	O	O	O
determined	determined	O	O	O	O
by	by	O	O	O	O
the	the	O	O	O	O
average	average	O	O	O	O
decrease	decrease	O	O	O	O
(	(	O	O	O	O
%	%	O	O	O	O
)	)	O	O	O	O
in	in	O	O	O	O
mean	mean	O	O	O	O
arterial	arterial	O	O	O	O
pressure	pressure	O	O	O	O
(	(	O	O	O	O
MAP	map	O	O	OTHERS	I
femoral	femoral	O	O	O	O
)	)	O	O	O	O
over	over	O	O	O	O
the	the	O	O	O	O
60-s	60-s	O	O	O	O
tilt	tilt	O	O	O	O
period	period	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
basal	basal	O	O	O	O
MAP	map	O	O	OTHERS	I
of	of	O	O	O	O
conscious	conscious	O	O	O	O
SHR	shr	O	O	O	O
was	was	O	O	O	O
reduced	reduced	O	O	O	O
to	to	O	O	O	O
a	a	O	O	O	O
similar	similar	O	O	O	O
extent	extent	O	O	O	O
by	by	O	O	O	O
prazosin	prazosin	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
-23%(-)-26	-23%(-)-26	O	O	O	O
%	%	O	O	O	O
MAP	map	O	O	OTHERS	I
)	)	O	O	O	O
and	and	O	O	O	O
rauwolscine	rauwolscine	O	O	OTHERS	I
(	(	O	O	O	O
-16%(-)-33	-16%(-)-33	O	O	O	O
%	%	O	O	O	O
MAP	map	O	O	OTHERS	I
)	)	O	O	O	O
.	.	O	O	O	O

However	however	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
head-up	head-up	O	O	O	O
tilt	tilt	O	O	O	O
induced	induced	O	O	O	O
orthostatic	orthostatic	O	DISEASE	OTHERS	I
hypotension	hypotension	O	DISEASE	OTHERS	I
in	in	O	O	O	O
the	the	O	O	O	O
SHR	shr	O	O	O	O
treated	treated	O	O	O	O
with	with	O	O	O	O
prazosin	prazosin	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
-16	-16	O	O	O	O
%	%	O	O	O	O
MAP	map	O	O	OTHERS	I
,	,	O	O	O	O
n	n	O	O	OTHERS	I
=	=	O	O	O	O
6	6	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
but	but	O	O	O	O
not	not	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
SHR	shr	O	O	O	O
treated	treated	O	O	O	O
with	with	O	O	O	O
rauwolscine	rauwolscine	O	O	OTHERS	I
(	(	O	O	O	O
less	less	O	O	O	O
than	than	O	O	O	O
+	+	O	O	O	O
2	2	O	O	O	O
%	%	O	O	O	O
MAP	map	O	O	OTHERS	I
,	,	O	O	O	O
n	n	O	O	OTHERS	I
=	=	O	O	O	O
6	6	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

3	3	O	O	O	O
.	.	O	O	O	O
Conscious	conscious	O	O	O	O
SHR	shr	O	O	O	O
were	were	O	O	O	O
treated	treated	O	O	O	O
for	for	O	O	O	O
4	4	O	O	O	O
days	days	O	O	O	O
with	with	O	O	O	O
prazosin	prazosin	CHEMICALS	O	OTHERS	I
at	at	O	O	O	O
2	2	O	O	O	O
mg	mg	O	O	OTHERS	I
kg-1	kg-1	O	O	O	O
day-1	day-1	O	O	O	O
i.p	i.p	O	O	O	O
.	.	O	O	O	O
for	for	O	O	O	O
chronic	chronic	O	O	O	O
alpha	alpha	O	O	O	O
1-adrenoceptor	1-adrenoceptor	O	O	O	O
blockade	blockade	O	O	O	O
.	.	O	O	O	O

MAP	map	O	O	OTHERS	I
in	in	O	O	O	O
conscious	conscious	O	O	O	O
SHR	shr	O	O	O	O
after	after	O	O	O	O
chronic	chronic	O	O	O	O
prazosin	prazosin	CHEMICALS	O	OTHERS	I
treatment	treatment	O	O	O	O
was	was	O	O	O	O
14	14	O	O	O	O
%	%	O	O	O	O
lower	lower	O	O	O	O
than	than	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
untreated	untreated	O	O	O	O
SHR	shr	O	O	O	O
(	(	O	O	O	O
n	n	O	O	OTHERS	I
=	=	O	O	O	O
8)	8)	O	O	O	O
.	.	O	O	O	O

Head-up	head-up	O	O	O	O
tilts	tilts	O	O	O	O
in	in	O	O	O	O
these	these	O	O	O	O
rats	rats	O	O	O	O
did	did	O	O	O	O
not	not	O	O	O	O
produce	produce	O	O	O	O
orthostatic	orthostatic	O	DISEASE	OTHERS	I
hypotension	hypotension	O	DISEASE	OTHERS	I
when	when	O	O	O	O
performed	performed	O	O	O	O
either	either	O	O	O	O
prior	prior	O	O	O	O
to	to	O	O	O	O
or	or	O	O	O	O
after	after	O	O	O	O
acute	acute	O	O	O	O
dosing	dosing	O	O	O	O
of	of	O	O	O	O
prazosin	prazosin	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
0.1	0.1	O	O	O	O
mg	mg	O	O	OTHERS	I
kg-1	kg-1	O	O	O	O
i.p	i.p	O	O	O	O
.	.	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Conversely	conversely	O	O	O	O
,	,	O	O	O	O
administration	administration	O	O	O	O
of	of	O	O	O	O
rauwolscine	rauwolscine	O	O	OTHERS	I
(	(	O	O	O	O
3	3	O	O	O	O
mg	mg	O	O	OTHERS	I
kg-1	kg-1	O	O	O	O
i.v	i.v	O	O	O	O
.	.	O	O	O	O
)	)	O	O	O	O
in	in	O	O	O	O
chronic	chronic	O	O	O	O
prazosin	prazosin	CHEMICALS	O	OTHERS	I
treated	treated	O	O	O	O
SHR	shr	O	O	O	O
decreased	decreased	O	O	O	O
the	the	O	O	O	O
basal	basal	O	O	O	O
MAP	map	O	O	OTHERS	I
by	by	O	O	O	O
12	12	O	O	O	O
-	-	O	O	O	O
31	31	O	O	O	O
%	%	O	O	O	O
(	(	O	O	O	O
n	n	O	O	OTHERS	I
=	=	O	O	O	O
4	4	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
subsequent	subsequent	O	O	O	O
tilts	tilts	O	O	O	O
induced	induced	O	O	O	O
further	further	O	O	O	O
drops	drops	O	O	O	O
of	of	O	O	O	O
MAP	map	O	O	OTHERS	I
by	by	O	O	O	O
19	19	O	O	O	O
-	-	O	O	O	O
23	23	O	O	O	O
%	%	O	O	O	O
in	in	O	O	O	O
these	these	O	O	O	O
rats	rats	O	O	O	O
.	.	O	O	O	O

4	4	O	O	O	O
.	.	O	O	O	O
The	the	O	O	O	O
pressor	pressor	O	O	O	O
responses	responses	O	O	O	O
and	and	O	O	O	O
bradycardia	bradycardia	O	DISEASE	OTHERS	I
to	to	O	O	O	O
the	the	O	O	O	O
alpha	alpha	O	O	O	O
1-agonist	1-agonist	O	O	O	O
cirazoline	cirazoline	O	O	OTHERS	I
(	(	O	O	O	O
0.6	0.6	O	O	O	O
and	and	O	O	O	O
2	2	O	O	O	O
micrograms	micrograms	O	O	O	O
kg-1	kg-1	O	O	O	O
i.v	i.v	O	O	O	O
.	.	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
alpha	alpha	O	O	O	O
2-agonist	2-agonist	O	O	O	O
Abbott-53693	abbott-53693	O	O	OTHERS	I
(	(	O	O	O	O
1	1	O	O	O	O
and	and	O	O	O	O
3	3	O	O	O	O
micrograms	micrograms	O	O	O	O
kg-1	kg-1	O	O	O	O
i.v	i.v	O	O	O	O
.	.	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
noradrenaline	noradrenaline	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
0.1	0.1	O	O	O	O
and	and	O	O	O	O
1.0	1.0	O	O	O	O
micrograms	micrograms	O	O	O	O
kg-1	kg-1	O	O	O	O
i.v	i.v	O	O	O	O
.	.	O	O	O	O
)	)	O	O	O	O
were	were	O	O	O	O
determined	determined	O	O	O	O
in	in	O	O	O	O
conscious	conscious	O	O	O	O
SHR	shr	O	O	O	O
with	with	O	O	O	O
and	and	O	O	O	O
without	without	O	O	O	O
chronic	chronic	O	O	O	O
prazosin	prazosin	CHEMICALS	O	OTHERS	I
pretreatment	pretreatment	O	O	O	O
.	.	O	O	O	O

Both	both	O	O	O	O
the	the	O	O	O	O
pressor	pressor	O	O	O	O
and	and	O	O	O	O
bradycardia	bradycardia	O	DISEASE	OTHERS	I
effects	effects	O	O	O	O
of	of	O	O	O	O
cirazoline	cirazoline	O	O	OTHERS	I
were	were	O	O	O	O
abolished	abolished	O	O	O	O
in	in	O	O	O	O
chronic	chronic	O	O	O	O
prazosin	prazosin	CHEMICALS	O	OTHERS	I
treated	treated	O	O	O	O
SHR	shr	O	O	O	O
(	(	O	O	O	O
n	n	O	O	OTHERS	I
=	=	O	O	O	O
4	4	O	O	O	O
)	)	O	O	O	O
as	as	O	O	O	O
compared	compared	O	O	O	O
to	to	O	O	O	O
the	the	O	O	O	O
untreated	untreated	O	O	O	O
SHR	shr	O	O	O	O
(	(	O	O	O	O
n	n	O	O	OTHERS	I
=	=	O	O	O	O
4	4	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

On	on	O	O	O	O
the	the	O	O	O	O
other	other	O	O	O	O
hand	hand	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
pressor	pressor	O	O	O	O
effects	effects	O	O	O	O
of	of	O	O	O	O
Abbott-53693	abbott-53693	O	O	OTHERS	I
were	were	O	O	O	O
similar	similar	O	O	O	O
in	in	O	O	O	O
both	both	O	O	O	O
groups	groups	O	O	O	O
of	of	O	O	O	O
SHR	shr	O	O	O	O
,	,	O	O	O	O
but	but	O	O	O	O
the	the	O	O	O	O
accompanying	accompanying	O	O	O	O
bradycardia	bradycardia	O	DISEASE	OTHERS	I
was	was	O	O	O	O
greater	greater	O	O	O	O
in	in	O	O	O	O
SHR	shr	O	O	O	O
with	with	O	O	O	O
chronic	chronic	O	O	O	O
prazosin	prazosin	CHEMICALS	O	OTHERS	I
treatment	treatment	O	O	O	O
than	than	O	O	O	O
without	without	O	O	O	O
such	such	O	O	O	O
treatment	treatment	O	O	O	O
.	.	O	O	O	O

Furthermore	furthermore	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
bradycardia	bradycardia	O	DISEASE	OTHERS	I
that	that	O	O	O	O
accompanied	accompanied	O	O	O	O
the	the	O	O	O	O
noradrenaline-induced	noradrenaline-induced	O	O	O	O
pressor	pressor	O	O	O	O
effect	effect	O	O	O	O
in	in	O	O	O	O
SHR	shr	O	O	O	O
was	was	O	O	O	O
similar	similar	O	O	O	O
with	with	O	O	O	O
and	and	O	O	O	O
without	without	O	O	O	O
chronic	chronic	O	O	O	O
prazosin	prazosin	CHEMICALS	O	OTHERS	I
treatment	treatment	O	O	O	O
despite	despite	O	O	O	O
a	a	O	O	O	O
47	47	O	O	O	O
-	-	O	O	O	O
71	71	O	O	O	O
%	%	O	O	O	O
reduction	reduction	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
pressor	pressor	O	O	O	O
effect	effect	O	O	O	O
in	in	O	O	O	O
chronic	chronic	O	O	O	O
alpha	alpha	O	O	O	O
1-receptor	1-receptor	O	O	O	O
blocked	blocked	O	O	O	O
SHR.(ABSTRACT	shr.(abstract	O	O	O	O
TRUNCATED	truncated	O	O	O	O
AT	at	O	O	O	O
400	400	O	O	O	O
WORDS	words	O	O	O	O
)	)	O	O	O	O

